@article{d5c1c150f2ce491995d45471e9955824,
title = "Can pharmacotherapy effectively reduce Alzheimer{\textquoteright}s related agitation?",
abstract = "N/A",
keywords = "Agitation, Alzheimer{\textquoteright}s disease, aggression, amyloid-β, brexpiprazole, cannabinoids, citalopram, dextromethorphan/quinidine, electroconvulsive therapy, nabilone, Agitation, Alzheimer{\textquoteright}s disease, aggression, amyloid-β, brexpiprazole, cannabinoids, citalopram, dextromethorphan/quinidine, electroconvulsive therapy, nabilone",
author = "Madia Lozupone and {La Montagna}, Maddalena and Rodolfo Sardone and Davide Seripa and Antonio Daniele and Francesco Panza",
year = "2020",
doi = "10.1080/14656566.2020.1770730",
language = "English",
volume = "21",
pages = "1517--1522",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "-London United Kingdom:Informa Healthcare -London , United Kingdom: Ashley Publications Limited",
}